Abstract
Folate is vital for cell development and growth. It is involved in one-carbon transfer reactions essential for the synthesis of purines and pyrimidines. It also acts in conjunction with cobalamin (vitamin B12) as a fundamental cofactor in the remethylation cycle that converts homocysteine to methionine. A deficiency in folate or vitamin B12 can lead to elevated homocysteine level, which has been identified as an independent risk factor in several health-related conditions. Adequate folate levels are essential in women of childbearing age and in pregnant women, and folate deficiency is associated with several congenital malformations. Low folate levels can be caused by dietary deficiencies, a genetic predisposition or treatment with medicines that affect folate concentration. Women who are pregnant or of child-bearing age commonly use medicines, so it is important to identify the basic biochemical mechanisms by which medicines interfere with the folate–homocysteine–methionine pathway. This review focuses on prescription medicines associated with folate disruption. It also summarizes their undesirable/toxic effects. Recommendations regarding folate supplementation during medical therapy are also reviewed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adjei AA (2003) Pemetrexed (Alimta): a novel multitargeted antifolate agent. Expert Rev Anticancer Ther 3(2):145–156. https://doi.org/10.1586/14737140.3.2.145
Agbenorku P (2013) Review article. Orofacial clefts: a worldwide review of the problem. ISRN Plast Surg 1–7. https://doi.org/10.5402/2013/348465
Aghamohammadi V, Gargari BP, Aliasgharzadeh A (2011) Effects of folic acid supplementation on homocysteine, serum total antioxidant capacity, and malondialdehyde in patients with type 2 diabetes mellitus. J Am Coll Nutr 30(3):210–215. https://doi.org/10.1080/07315724.2011.10719962
Alati T, Worzalla JF, Shih C, Bewley JR, Lewis S, Moran RG, Grindey GB (1996) Augmentation of the therapeutic activity of lometrexol [(6R)5,10-dideazatetrahydrofolate] by oral folic acid. Cancer Res 56:2331–2335
Allen RH, Stabler SP, Savage DG, Lindenbaum J (1990) Diagnosis of cobalamin deficiency I: usefulness of serum methylmalonic acid and total homocysteine concentrations. Am J Hematol 34:90–98. https://doi.org/10.1002/ajh.2830340204
American Academy of Neurology (2009) An summary of evidence-based guideline for patients and their families. Drug risks and safety during pregnancy, women with epilepsy. American Academy of Neurology, New York
Apeland T, Mansoor MA, Strandjord RE (2001a) Antiepileptic drugs as independent predictors of plasma total homocysteine levels. Epilepsy Res 47(1–2):27–35. https://doi.org/10.1016/S0920-1211(01)00288-1
Apeland T, Mansoor MA, Strandjord RE, Vefring H, Kristensen O (2001b) Folate, homocysteine and methionine loading in patients on carbamazepine. Acta Neurol Scand 103:294–299. https://doi.org/10.1034/j.1600-0404.2001.103005294.x
Arakawa T, Honda Y, Narisawa K (1973) Mechanism of decrease in serum folate levels of rats receiving diphenylhydantoin. Tohoku J Exp Med 111(3):203–210. https://doi.org/10.1620/tjem.111.203
Arcot J, Shrestha A (2005) Folate: methods of analysis. Trends Food Sci Technol 16(6–7):253–266. https://doi.org/10.1016/j.tifs.2005.03.013
Attilakos A, Papakonstantinou E, Schulpis K, Voudris K, Katsarou E, Mastroyianni S, Garoufi A (2006) Early effect of sodium valproate and carbamazepine monotherapy on homocysteine metabolism in children with epilepsy. Epilepsy Res 71(2–3):229–232. https://doi.org/10.1016/j.eplepsyres.2006.06.015
Avendaño C, Menédez JC (2008) Medicinal chemistry of anticancer drugs. Chapter 2—Antimetabolites, pp 9–52
Baggott JE, Morgan SL, Ha T, Vaughn WH, Hine RJ (1992) Inhibition of folate-dependent enzymes by non-steroidal anti-inflammatory drugs. Biochem J 282(Pt 1):197–202. https://doi.org/10.1042/bj2820197
Bailey N, Humphreys A, Laohavinij S, Lind M, Robson L, Calvert A (1995) Oral folic acid improves lometrexol toxicity profile: a phase I study. Eur J Cancer 31(6):S193–S194
Bajetta E, Celio L, Buzzoni R, Ferrari L, Marchianó A, Martinetti A, Longarini R, Becerra C, Ilardi C, John W (2003) Phase II study of pemetrexed disodium (Alimta) administered with oral folic acid in patients with advanced gastric cancer. Ann Oncol 14(10):1543–1548. https://doi.org/10.1093/annonc/mdg406
Belcastro V, Striano P, Gorgone G, Costa C, Ciampa C, Caccamo D, Pisani LR, Oteri G, Marciani MG, Aguglia U, Striano S, Ientile R, Calabresi P, Pisani F (2010) Hyperhomocysteinemia in epileptic patients on new antiepileptic drugs. Epilepsia 51(2):274–279. https://doi.org/10.1111/j.1528-1167.2009.02303.x
Blom HJ (2009) Folic acid, methylation and neural tube closure in humans. Birth Defects Res A Clin Mol Teratol 85(4):295–302. https://doi.org/10.1002/bdra.20581
Bottiglieri T (2005) Homocysteine and folate metabolism in depression. Prog Neuro-Psyhopharmacol Biol Psychiatry 29:1103–1112. https://doi.org/10.1016/j.pnpbp.2005.06.021
Bottiglieri T, Reynolds E (2010) Folate and neurological disease, basic mechanisms. Folate in health and diseases, 2nd edn. Taylor & Francis Group LLC, London, pp 355–380
Brito LA (2012) Review article: Genetics and management of the patient with orofacial cleft. Plast Surg Int 1–11. https://doi.org/10.1155/2012/782821
Brouwer IA, van Dusseldorp M, West CE, Meyboom S, Thomas CM, Duran M, van het Hof KH, Eskes TK, Hautvast JG, Steegers-Theunissen RP (1999) Dietary folate from vegetables and citrus fruit decreases plasma homocysteine concentrations in humans in a dietary controlled trial. J Nutr 129(6):1135–1139. https://doi.org/10.1093/jn/129.6.1135
Brunet L, Miranda J, Farré M, Berini L, Mendieta C (1996) Gingvial enlargement induced by drugs. Drug Saf 15:219–231
Busti AJ (2017) Medications know to decrease vitamin B12 levels. https://www.ebmconsult.com/articles/vitamin-b12-medication-interactions-lower-levels. Accessed 9 Aug 2017
Canfield MA, Collins JS, Botto LD, Williams LJ, Mai CT, Kirby RS, Pearson K, Devine O, Mulinare J (2005) Changes in the birth prevalence of selected birth defects after grain fortification with folic acid in the United States: Findings from a multi-state population-based study. Birth Defects Res A Clin Mol Teratol 73:679–689. https://doi.org/10.1002/bdra.20210
Carreras CW, Santi DV (1995) The catalytic mechanism and structure of thymidylate synthase. Ann Rev Biochem 64:721–762. https://doi.org/10.1146/annurev.bi.64.070195.003445
Chen CP (2008) Syndromes, disorders and maternal risk factors associated with neural tube defects (II). Taiwan J Obstet Gynecol 47:10–17. https://doi.org/10.1016/S1028-4559(08)60122-9
Clarke SJ, Beale PJ, Rivory LP (2000) Clinical and preclinical pharmacokinetics of raltitrexed. Clin Pharmacokinet 39(6):429–443. https://doi.org/10.2165/00003088-200039060-00004
Cody V, Schwalbe CH (2006) Structural characteristics of antifolate dihydrofolate reductase enzyme interactions. Crystallogr Rev 12(4):301–333. https://doi.org/10.1080/08893110701337727
Cody V, Galitsky N, Rak D, Luft JR, Pangborn W, Queener SF (1999) Ligand-induced conformational changes in the crystal structures of Pneumocystis carinii dihydrofolate reductase complexes with folate and NADP+. Biochemistry 38:4303. https://doi.org/10.1021/bi982728m
Cole PD, Kamen BA, Bertino JR (2010) Section 13: Chemotherapeutic agents. In: Frei H (ed) Cancer medicine, 8th edn. People’s Medical Publishing House, Shelton, pp 611–621
Corominas-Faja B, Quirantes-Piné R, Oliveras-Ferraros C, Vazquez-Martin A, Cufí S, Martin-Castillo B, Micol V, Joven J, Segura-Carretero A, Menendez JA (2012) Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging (Albany NY) 4(7):480–498. https://doi.org/10.18632/aging.100472
Crandall BF, Corson VL, Evans MI, Goldberg JD, Knight G, Salafsky IS (1998) American College of Medical Genetics statement on folic acid: fortification and supplementation. Am J Med Genet 78(4):381
Csáky-Szunyogh M, Vereczkey A, Kósa Z, Czeizel AE (2013) Association of maternal diseases during pregnancy with the risk of single ventricular septal defects in the offspring- a population-based case-control study. J Matern Fetal Neonatal Med 26(8):738–747. https://doi.org/10.3109/14767058.2012.755170
Czeizel AE, Dudás I, Paput L, Bánhidy F (2011) Prevention of neural-tube defects with perisonceptional folic acid, methylfolate, or multivitamins? Ann Nutr Metab 58(4):263–271. https://doi.org/10.1159/000330776
Dansky LV, Andermann E, Rosenblatt D, Sherwin AL, Andermann F (1987) Anticonvulsants, folate levels, and pregnancy outcome: a prospective study. Ann Neurol 21(2):176–182. https://doi.org/10.1002/ana.410210210
Dastur DK, Dave UP (1987) Effect of prolonged anticonvulsant medication in epileptic patients: serum lipids, vitamins B6, B12, and folic acid, proteins, and fine structure of liver. Epilepsia 28(2):147–159. https://doi.org/10.1111/j.1528-1157.1987.tb03641.x
De Mattia E, Toffoli G (2009) C677T and A1298C MTHFR polymorphisms, a challenge for antifolate and fluoropyrimidine-based therapy personalisation. Eur J Cancer 45(8):1333–1351. https://doi.org/10.1016/j.ejca.2008.12.004
de Vries EG, Gietema JA, Workman P, Scott JE, Crawshaw A, Dobbs HJ, Dennis I, Mulder NH, Sleijfer DT, Willemse PH (1993) A phase II and pharmacokinetic study with oral piritrexim for metastatic breast cancer. Br J Cancer 68(3):641–644
De Wit R, Kaye SB, Roberts JT, Stoter G, Scott J, Verweij J (1993) Oral piritrexim, an effective treatment for metastatic urothelial cancer. Br J Cancer 67(2):388–390
de Jager J, Kooy A, Lehert P, Wulffelé MG, van der Kolk J, Bets D, Verburg J, Donker AJ, Stehouwer CD (2010) Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomized placebo controlled trial. BMJ 340:c2181. https://doi.org/10.1136/bmj.c2181
De-Regil LM, Fernández-Gaxiola AC, Dowswell T, Peña-Rosas JP (2010) Effects and safety of periconceptional folate supplementation for preventing birth defects. Cochrane Database Syst Rev CD007950. https://doi.org/10.1002/14651858.CD007950.pub2
DeSoto MC, Hitlan R (2012) Synthetic folic acid supplementation during pregnancy may increase the risk of developing autism. J Pediatr Biochem 2(4):251–261. https://doi.org/10.3233/JPB-120066
Desouza C, Keebler M, McNamara DB, Fonseca V (2002) Drugs affecting homocysteine metabolism: impact on cardiovascular risk. Drugs 62(4):605–616
Dierkes J, Luley C, Westphal S (2007) Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels. Vasc Health Risk Manag 3(1):99–108
Duch DS, Edelstein MP, Bowers SW, Nichol CA (1982) Biochemical and chemotherapeutic studies on 2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d] pyrimidine (BW 301 U), a novel lipid-soluble inhibitor of dihydrofolate reductase. Cancer Res 42:3987–3994
Durand P, Prost M, Blache D (1997) Folic acid deficiency enhances oral contraceptive-induced platelet hyperactivity. Arterioscler Thromb Vasc Biol 17(10):1939–1946
Ekinci RMK, Balci S, Serbes M, Dogruel D, Altintas DU, Yilmaz M (2018) Decreased serum vitamin B12 and vitamin D levels affect sleep quality in children with familial mediterranean fever. Rheumatol Int 38(1):83–87. https://doi.org/10.1007/s00296-017-3883-2
Eldeen ON, Eldayem SMA, Shatla RH, Omara NA, Elgammal SS (2012) Homocysteine, folic acid and vitamin B12 levels in serum of epileptic children. Egypt J Med Hum Genet 13(3):275–280. https://doi.org/10.1016/j.ejmhg.2012.05.002
EMA (2017) New measures to avoid valproate exposure in pregnancy endorses. http://www.ema.europa.eu/docs/en_GB/document_library/Referrals_document/Valproate_2017_31/Position_provided_by_CMDh/WC500246350.pdf. Accessed 25 Mar 2018
EMA (2018a) Europa. Scientific discussion: Alimta. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Scientific_Discussion/human/000564/WC500025606.pdf Accessed 24 Mar 2018
EMA (2018b) Europa. Summary of the product characteristics: Jylamvo. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_-_Product_Information/human/003756/WC500225925.pdf. Accesed 17 Mar 2018
EMA (2018c) Pralaterexate European public assesment report. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_Public_assessment_report/human/002096/WC500129886.pdf. Accessedd 18 Mar 2018
eMC (2018a) Salazopyrin En-Tabs. https://www.medicines.org.uk/emc/product/6686/smpc. Accessed 18 Mar 2018
eMC (2018b) Questran powder for oral suspension 4 g. Bristol-Myers Squibb Pharmaceutical Limited. https://www.medicines.org.uk/emc/product/5715/smpc. Accessed 20 June 2018
eMC (2018c) Tegretol liquid 100 mg/5 mL. Novartis Pharmaceuticals UK Ltd. https://www.medicines.org.uk/emc/product/1041/smpc. Accessed 20 June 2018
eMC (2018d) Cilest 35/250 micrograms film-coated tablets. Janssen-Cilag Ltd. https://www.medicines.org.uk/emc/product/6900/smpc. Accessed 20 June 2018
eMC (2018e) Aidulan 20/75 microgram film-coated tablets. Lupin Healthcare (UK) Ltd. https://www.medicines.org.uk/emc/product/5079/smpc. Accessed 20 June 2018
eMC (2018f) Loestrin 20. Galen Limited. https://www.medicines.org.uk/emc/product/1060/smpc. Accessed 20 June 2018
eMC (2018g) Tagamet 200 mg tablets. Chemidex Pharma Ltd. https://www.medicines.org.uk/emc/product/6493/smpc. Accessed 20 June 2018
eMC (2018h) Primidone 250 mg tablet. SERB. https://www.medicines.org.uk/emc/product/2940/smpc. Accessed 20 June 2018
eMC (2018i) Phenobarbital Accord 15 mg tablets. Accord-UK Ltd. https://www.medicines.org.uk/emc/product/2057/smpc. Accessed 20 June 2018
eMC (2018j) Epanutin Infatabs. Pfizer Limited. https://www.medicines.org.uk/emc/product/2259/smpc. Accessed 20 June 2018
eMC (2018k) Trimethoprim 200 mg tablets. Aurobindo Pharma-Milpharm Ltd. https://www.medicines.org.uk/emc/product/7042/smpc. Accessed 20 June 2018
Eunice Kennedy Shriver Nation Institute of Children Health and Human Development (NIH) (2017) Neural tube defects (NTDs): condition information. https://www.nichd.nih.gov/health/topics/ntds/conditioninfo/default. Accessed 18 June 2018
European Food Safety Authority (EFSA) (2014) Scientific opinion on the evaluation of allergenic foods and food ingredients for labelling purposes. EFSA J 12:1–227. https://doi.org/10.2903/j.efsa.2014.3894
Fathe K, Palacios A, Finnell RH (2014a) Brief report novel mechanism for valproate-induced teratogenicity. Birth Defects Res A Clin Mol Teratol 100(8):592–597. https://doi.org/10.1002/bdra.23277
Fathe K, Palacios A, Finnell RH (2014b) Novel mechanism for valproate-induced teratogenicity. Birth Defects A Clin Mol Teratol 100(8):592–597. https://doi.org/10.1002/bdra.23277
FDA Label (2009) Folotyn (pralatrexate injection). https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/022468lbl.pdf. Accessed 18 March 2018
FDA Label (2017a) DARAPRIM (pyrimethamine). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/008578s020lbl.pdf. Accessed 18 Mar 2018
FDA Label (2017b) BEYAZ (drospirenone/ethinyl estradiol/levomefolate calcium tablets and levomefolate calcium tablets), for oral use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022532s009lbl.pdf. Accessed 2 Apr 2018
FDA Label (2017c) Glucophage (metformin hydrochloride). https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/020357s037s039,021202s021s023lbl.pdf. Accessed 2 Apr 2018
FDA Label (2018) Dapakote ER (divalpreoex sodium) extended-release tablets, for oral use. https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/021168s038lbl.pdf. Accessed 20 June 2018
Force RW, Nahata MC (1992) Effect of histamine H2-receptor antagonists on vitamin B12 absorption. Ann Pharmacother 26(10):1283–1286. https://doi.org/10.1177/106002809202601018
Gatford KL, Houda CM, Lu ZX, Coat S, Baghurst PA, Owens JA, Sikaris K, Rowan JA, Hague WM (2013) Vitamin B12 and homocysteine status during pregnancy in the metformin in gestational diabetes trial: responses to maternal metformin compared with insulin treatment. Diabetes Obes Metab 15(7):660–667. https://doi.org/10.1111/dom.12080
Geda G, Caksen H, Içağasioğlu D (2002) Serum lipids, vitamin B12 and folic acid levels in children receiving long-term valproate therapy. Acta Neurol Belg 102(3):122–126
Gemici AI, Sevindik ÖG, Akar S, Tunca M (2013) Vitamin B12 levels in familial mediterranean fever patients treated with colchicine. Clin Exp Rheumatol 31(3):57–59
Gervasio JM (2010) Drug-induced changes to nutritional status. In: Boullata JI, Armenti VT (eds) Handbook of drug-nutrient interactions, 2nd edn, pp 423–445
Gidal BE, Tamura T, Hammer A, Vuong A (2005) Blood homocysteine, folate and vitamin B-12 concentrations in patients with epilepsy receiving lamotrigine or sodium valproate for initial monotherapy. Epilepsy Res 64(3):161–166. https://doi.org/10.1016/j.eplepsyres.2005.03.005
Gil-da-Silva-Lopes VL, Lopes Monlleó I (2013) Risk factor and the prevention of oral clefts. In: 18th congress of the Brazilian Association for Oral Health Promotion, pp 1–5. https://doi.org/10.1590/S1806-83242014.50000008
Girdwood RH (1973) Trimethoprim/sulphamethoxazole: long-term therapy and folate levels. Med J Aust (Suppl) 1:34–36
Gish RH, Porta C, Lazar L, Ruff P, Feld R, Croitoru A, Feun L, Jeziorski K, Leighton J, Gallo J, Kennealey GT (2007) Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. J Clin Oncol 25(21):3069–3075. https://doi.org/10.1200/JCO.2006.08.4046
Green TJ, Houghton LA, Donovan U, Gibson RS, O’Connor DL (1998) Oral contraceptives did not affect biochemical folate indexes and homocysteine concentrations in adolescent females. J Am Diet Assoc 98:49–55. https://doi.org/10.1016/S0002-8223(98)00014-5
Habeck LL, Leitner TA, Shackelford KA, Gossett LS, Schultz RM, Andis SL, Shih C, Grindey GB, Mendelsohn LG (1994) A novel class of monoglutamated antifolates exhibits tight-binding inhibition of human glycinamide ribonucleotide formyltransferase and potent activity against solid tumors. Cancer Res 54(4):1021–1026
Hagner N, Joerger M (2010) Cancer chemotherapy: targeting folic acid synthesis. Cancer Manag Res 2:293–301. https://doi.org/10.2147/CMR.S10043
Halwachs S, Kneuer C, Honscha W (2007) Downregulation of the reduced folate carrier transport activity by phenobarbital-type cytochrome P450 inducers and protein kinase C activators. Biochim Biophys Acta 1768(6):1671–1679. https://doi.org/10.1016/j.bbamem.2007.03.023
Halwachs S, Lakoma C, Schäfer I, Seibei P, Honscha W (2011) The antiepileptic drugs phenobarbital and carbamazepine reduce transport of methotrexate in rat choroid plexus by down-regulation of the reduced folate carrier. Mol Pharmacol 80(4):621–629. https://doi.org/10.1124/mol.111.072421
Hernandez-Diaz S, Werler MM, Walker AM, Mitchell AA (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Engl J Med 343:1608–1614. https://doi.org/10.1056/NEJM200011303432204
Hiraoka M, Kagawa Y (2017) Genetic polymorphisms and folate status. Congenit Amon (Kyoto) 57(5):142–149. https://doi.org/10.1111/cga.12232
Hitchings GH, Burchall JJ (1965) Inhibition of folate biosynthesis and function as a basis for chemotherapy. Adv Enzymol Relat Areas Mol Biol 27:417–468
Holmes LB, Wyszynski DF, Lieberman E (2004) The AED (antiepileptic drug) pregnancy registry: a 6-year experience. Arch Neurol 61(5):673–678. https://doi.org/10.1001/archneur.61.5.673
Homocysteine Lowering Trialists’ Collaboration (2005) Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 82:806–812. https://doi.org/10.1093/ajcn/82.4.806
Honein MA, Gilboa SM, Broussard CS (2013) The need for safer medication use in pregnancy. Expert Rev Clin Pharmacol 6(5):453–455. https://doi.org/10.1586/17512433.2013.827401
Hughes A, Calvert AH (1999) Preclinical and clinical studies with the novel thymidylate synthase inhibitor nolatrexed dihydrochloride (Thymitaq™, AG337). In: Jackman AL (ed) Antifolate drugs in cancer therapy. Cancer drug discovery and development. Humana Press, Totowa
Isojärvi JIT, Pakarinen AJ, Myllylä VV (1997) Basic haematological parameters, serum gamma-glutamyl-transferase activity, and erythrocyte folate and serum vitamin B12 levels during carbamazepine and oxcarbazepine therapy. Seizure 6(3):201–211. https://doi.org/10.1016/S1059-1311(97)80007-6
IUPAC-IUB Commission on Biochemical Nomenclature (1965) Nomenclature and symbols for folic acid and related compounds. Biochim Biophys Acta 107:11–13. https://doi.org/10.1111/j.1432-1033.1987.tb13413.x
Jansen G, van der Heijden J, Oerlemans R, Lems WF, Ifergan I, Scheper RJ, Assaraf YG, Dijkmans BA (2004) Sulfasalazine is a potent inhibitor of the reduced folate carrier: implications for combination therapies with methotrexate in rheumatoid arthritis. Arthritis Rheum 50(7):2130–2139. https://doi.org/10.1002/art.20375
Jhawer M, Rosen L, Dancey J, Hochster H, Hamburg S, Tempero M, Clendeninn N, Mani S (2007) Phase II trial of nolatrexed dihydrochloride [Thymitaq, AG 337] in patients with advanced hepatocellular carcinoma. Investig New Drugs 25(1):85–94. https://doi.org/10.1007/s10637-006-9003-x
Johnson MA, Hawthorne NA, Brackett WR, Fischer JG, Gunter EW, Allen RH, Stabler SP (2003) Hyperhomocysteinemia and vitamin B-12 deficiency in elderly using title IIIc nutrition services. Am J Clin Nutr 77(1):211–220. https://doi.org/10.1093/ajcn/77.1.211
Jolivet J, Jansen G, Peters GJ, Pinard MF, Schornagel JH (1994) Leucovorin rescue of human cancer and bone marrow cells following edatrexate or methotrexate. Biochem Pharmacol 47(4):659–665. https://doi.org/10.1016/0006-2952(94)90128-7
Kahn SB, Fein SA, Brodsky I (1968) Effects of trimethoprim on folate metabolism in man. Clin Pharmacol Ther 9(5):550–560. https://doi.org/10.1002/cpt196895550
Källén B (2003) Maternal drug use and infant cleft lip/palate with special reference to corticoids. Cleft Palate Craniofac J 40(6):624–628. https://doi.org/10.1597/02-077
Kamen BA, Eibl B, Cashmore A, Bertino J (1984) Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitro. Biochem Pharmacol 33(10):1697–1699. https://doi.org/10.1016/0006-2952(84)90298-3
Kampman MT (2007) Folate status in women of childbearing age with epilepsy. Epilepsy Res 75(1):52–56. https://doi.org/10.1016/j.eplepsyres.2007.04.003
Karabiber H, Sonmezgoz E, Ozerol E, Yakinci C, Otlu B, Yologlu S (2003) Effects of valproate and carbamazepine on serum levels of homocysteine, vitamin B12, and folic acid. Brain Dev 25(2):113–115. https://doi.org/10.1016/S0387-7604(02)00163-8
Karalliedde L, Clarke SFJ, Collignon U, Karalliedde J (2010) Adverse drug interactions: a handbook for prescribers. Drugs to treat infections antibiotics—other antibiotics. CRC Press, London, pp 549–550
Karas Kuželički N, Šmid A, Kek T, Eberlinc A, Geršak K, Mlinarič-Raščan I (2018) Common polymorphism in the glycine N-methyltransferase gene as a novel risk factor for cleft lip with or without cleft palate. Int J Oral Maxillofac Surg 1–8. https://doi.org/10.1016/j.ijom.2018.06.001
Kim YL (2003) Role of folate in colon cancer development in progression. J Nutr 133(11):3731S–3739S. https://doi.org/10.1093/jn/133.11.3731S
Kishi T, Fujita N, Eguchi T, Ueda K (1997) Mechanism for reduction of serum folate by antiepileptic drugs during prolonged therapy. J Neurol Sci 145:109–112. https://doi.org/10.1016/S0022-510X(96)00256-0
Klipstein FA (1964) Subnormal serum folate and macrocytosis associated with anticonvulsant drug therapy. Blood 23:68–86
Koehn EM, Perissinotti LL, Moghram S, Prabhakar A, Lesley SA, Mathews II, Kohen A (2012) Folate binding site of flavin-dependent thymidylate synthase. Proc Natl Acad Sci USA 109(39):15722–15727. https://doi.org/10.1073/pnas.1206077109
Kremer JM, Galivan J, Streckfuss A, Kamen B (1986) Methotrexate metabolism analysis in blood and liver of rheumatoid arthritis patients. Association with hepatic folate deficiency and formation of polyglutamates. Arthritis Rheum 29(7):832–835. https://doi.org/10.1002/art.1780290703
Lam JR, Schneidej JL, Zhao W, Corley DA (2013) Proton pump inhibitor and histamine 2 receptor antagonist use and vitamin B12 deficiency. JAMA 310(22):2435–2442. https://doi.org/10.1001/jama.2013.280490
Lambie DG, Johnson RH (1985) Drugs and folate metabolism. Drugs 30(2):145–155
Larsson SC, Giovannucci E, Wolk A (2006) Folate intake, MTHFR polymorphisms, and a risk of esophageal, gastric, and pancreatic cancer: a meta-analysis. Gastroenterology 131:1271–1283. https://doi.org/10.1053/j.gastro.2006.08.010
Larsson SC, Giovannucci E, Wolk A (2007) Folate and risk of breast cancer: a meta-analysis. J Natl Cancer Inst 99:64–76. https://doi.org/10.1093/jnci/djk006
Levine SZ, Kodesh A, Viktorin A, Smith L, Uher R, Reichenberg A, Sandin S (2018) Association of maternal use of folic acid and multivitamin supplements in the period before and during pregnancy with the risk of autism spectrum disorder in offspring. JAMA Psychiatry 75(2):176–184. https://doi.org/10.1001/jamapsychiatry.2017.4050
Lewis DP, Van Dyke DC, Stumbo PJ, Berg MJ (1998) Drug and environmental factors associated with adverse pregnancy outcomes. Part I: Antiepileptic drugs, contraceptives, smoking, and folate. Ann Pharmacother 32(7–8):802–817. https://doi.org/10.1345/aph.17297
Li Z, Ren A, Zhang L, Ye R, Li S, Zheng J, Hong S, Wang T, Li Z (2006) Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Res A Clin Mol Teratol 76:237–240. https://doi.org/10.1002/bdra.20248
Li WX, Cheng F, Zhang AJ, Dai SX, Li GH, Lv WW, Zhou T, Zhang Q, Zhang H, Zhang T, Liu F, Liu D, Huang JF (2017) Folate deficiency and gene polymorphisms of MTHFR, MTR and MTRR elevate the hyperhomocysteinemia risk. Clin Lab 63(3):523–533. https://doi.org/10.7754/Clin.Lab.2016.160917
Liew SC, Gupta ED (2015) Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism: epidemiology, metabolism and the associated diseases. Eur J Med Genet 58(1):1–10. https://doi.org/10.1016/j.ejmg.2014.10.004
Lindenbaum J, Whitehead N, Reyner F (1975) Oral contraceptive hormones, folate metabolism, and the cervical epithelium. Am J Clin Nutr 28(4):346–353. https://doi.org/10.1093/ajcn/28.4.346
Linnebank M, Moskau S, Semmler A, Widman G, Stoffel-Wagner B, Weller M, Elger CE (2011) Antiepileptic drugs interact with folate and vitamin B12 serum levels. Ann Neurol 69(2):352–359. https://doi.org/10.1002/ana.22229
Linus Pauling Institute—Micronutrient Information Center (2016) Folate. http://lpi.oregonstate.edu/mic/vitamins/folate#drug-interactions.Accessed 21 Apr 2016
Lloyd KA (2013) A scientific review: mechanisms of valproate-mediated teratogenesis. Biosci Horiz 6:1–10. https://doi.org/10.1093/biohorizons/hzt003
Luo YL (2012) Association between MTHFR polymorphisms and orofacial cleft risk: a meta-analysis. Birth Defects Res A Clin Mol Teratol 94(4):237–244. https://doi.org/10.1002/bdra.23005
Lussana F, Zighetti ML, Bucciarelli P, Cugno M, Cattaneo M (2003) Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users. Thromb Res 112(1–2):37–41. https://doi.org/10.1016/j.thromres.2003.11.007
Mader MM, Henry JR (2007) Reference module in chemistry, molecular sciences and chemical engineering. Comprehensive medicinal chemistry II. 7.03—antimetabolites. Lilly Research Laboratories, Indianapolis, pp 55–79
Mahmood L (2014) The metabolic processes of folic acid and vitamin B12 deficiency. J Health Res Rev 1:5–9. https://doi.org/10.4103/2394-2010.143318
Mahmoud LB, Mdhaffar M, Frikha R, Ghozzi H, Hakim A, Sahnoun Z, Elloumi M, Zeghal K (2018) Use of MTHFR C677T polymorphism and plasma pharmacokinetics to predict methotrexate toxicity in patients with acute lymphoblastic leukemia. Adv Clin Exp Med. https://doi.org/10.17219/acem/69802
Marelli AJ, Mackie AS, Ionescu-Ittu R, Rahme E, Pilote L (2007) Congenital heart disease in the general population: changing prevalence and age distribution. Circulation 115:163–172. https://doi.org/10.1161/CIRCULATIONAHA.106.627224
Matherly LH, Hou Z, Deng Y (2007) Human reduced folate carrier: translation of basic biology to cancer etiology and therapy. Cancer Metastatis Rev 26(1):111–128. https://doi.org/10.1007/s10555-007-9046-2
Matsui MS, Rozovski SJ (1982) Drug–nutrient interaction. Clin Ther 4(6):423–440
Maughan T, James R, Kerr D, Ledermann J, McArdle C, Seymour M, Johnston C (2000) Excess treatment related deaths and impaired quality of life show raltitrexed is inferior to infusional 5FU regimen in the palliative chemotherapy of advanced colorectal cancer (CRC): final results of MRC CRO6 (abstract). Ann Oncol 11(Suppl 4):43
Mawhinney E, Campbell J, Craig J, Russell A, Smithson W, Parsons L, Robertson I, Irwin B, Morrison P, Liggan B, Delanty N, Hunt S, Morrow J (2012) Valproate and the risk for congenital malformations: Is formulation and dosage regime important? Seizure 21(3):215–218. https://doi.org/10.1016/j.seizure.2012.01.005
May RB, Sunder TR (1993) Hematologic manifestations of long-term valproate therapy. Epilepsia 34(6):1098–1101. https://doi.org/10.1111/j.1528-1157.1993.tb02139.x
McGuire JJ (2003) Anticancer antifolates: current status and future directions. Curr Pharm Des 9(31):2593–2613. https://doi.org/10.2174/1381612033453712
McKinnon PJ, Caldecott KW (2007) DNA strand break repair and human genetic disease. Annu Rev Genomics Hum Genet 8:37–55. https://doi.org/10.1146/annurev.genom.7.080505.115648
Meador K, Reynolds MW, Crean S, Fahrbach K, Probst C (2008) Pregnancy outcomes in women with epilepsy: a systematic review and meta-analysis of published pregnancy registries and cohorts. Epilepsy Res 81(1):1–13. https://doi.org/10.1016/j.eplepsyres.2008.04.022
Medicines.ie (2018) Tomudex 2 mg powder for solution for infusion. http://www.medicines.ie/medicine/17124/SPC/Tomudex+2+mg+Powder+for+Solution+for+Infusion. Accessed 18 Mar 2018
Meenan J, O´Hallinan E, Scott J, Weir DG (1996) Influence of sulfasalazine and olsalamine on colonic epithelial cell folate content in patients with ulcerative colitis. Inflamm Bowel Dis 2:163–167. https://doi.org/10.1097/00054725-199609000-00001
Mendelsohn LG, Shih C, Schultz RM, Worzalla JF (1996) Biochemistry and pharmacology of glycinamide ribonucleotide formyltransferase inhibitors: LY309887 and lometrexol. Investig New Drugs 14(3):287–294
Milman N (2012) Intersinal absorption of folic acid—new physiologic & molecular aspects. Indian J Med Res 136(5):725–728
Milstien S, Kapatos G, Levine RA, Shane B (2001) Chemistry and biology of pteridines and folates. In: Proceedings of the 12th international symposium on pteridines and folates. National Institutes of Health, Bethesda, 17–22 June 2001, pp 427–429
Mischoulon D, Zajecka J, Freeman MP, Fava M (2016) Does folic acid interfere with lamotrigine? Lancet Psychiatry 3(8):704–705. https://doi.org/10.1016/S2215-0366(16)30167-5
Morrell MJ (2002) Folic acid and epilepsy. Epilepsy Curr 2(2):31–34. https://doi.org/10.1046/j.1535-7597.2002.00017.x
Morrow LE, Grimsley EW (1999) Long-term diuretic therapy in hypertensive patients: effects on serum homocysteine, vitamin B6, vitamin B12, and red blood cell folate concentrations. South Med J 92(9):866–870. https://doi.org/10.1097/00007611-199909000-00003
Morrow J, Russell A, Guthrie E, Parsons L, Robertson I, Waddell R, Irwin B, McGivern RC, Morrison PJ, Craig J (2006) Malformation risks of antiepileptic drugs in pregnancy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 77:193–198. https://doi.org/10.1136/jnnp.2005.074203
Morrow JI, Hunt SJ, Russell AJ, Smithson WH, Parsons L, Robertson I, Waddell R, Irwin B, Morrison PJ, Craig JJ (2009) Folic acid use and major congenital malformations in offspring of women with epilepsy: a prospective study from the UK Epilepsy and Pregnancy Register. J Neurol Neurosurg Psychiatry 80(5):506–511. https://doi.org/10.1136/jnnp.2008.156109
Mulder B, Bijlsma MJ, Schuiling-Veninga CC, Morssink LP, van Puijenbroek E, Aarnoudse JG, Hak E, de Vries TW (2017) Risk versus benefits of medication use during pregnancy: what do women perceive? Patient Prefer Adherence 12:1–8. https://doi.org/10.2147/PPA.S146091
Nayyar AS, Nataraju B, Subhas GT (2012) Phenytoin–folate interactions: how far is safe folate supplementation in phenytoin treated epileptic patients? J Appl Pharm Sci 2(6):230–235. https://doi.org/10.7324/JAPS.2012.2641
Nazki FH, Sameer AS, Ganaie BA (2014) Folate: metabolism, genes, polymorphisms and the associated diseases.Gene 533:11–20. https://doi.org/10.1016/j.gene.2013.09.063
Ni G, Qin J, Li H, Chen Z, Zhou Y, Fang Z, Chen Y, Zhou J, Huang M, Zhou L (2015) Effects of antiepileptic drug monotherapy on one-carbon metabolism and DNA methylation in patients with epilepsy. PLoS One 10(4):e0125656. https://doi.org/10.1371/journal.pone.0125656
NICE (2016) National Institute for Health and Care Excellence. NICE guideline: epilepsies: diagnosis and management. https://www.nice.org.uk/guidance/cg137/chapter/1-Guidance#women-and-girls-with-epilepsy. Accessed 25 Mar 2018
NIDDK U.S. (2017) National library of medicine: trimetrexate. https://livertox.nih.gov/Trimetrexate.htm. Accessed 22 Oct 2017
NIH (2016a) Folate—dietary supplement fact sheet. https://ods.od.nih.gov/factsheets/Folate-HealthProfessional. Accessed 28 Jan 2016
NIH (2016b) Lamotrigine. https://www.nlm.nih.gov/medlineplus/druginfo/meds/a695007.html. Accessed 6 May 2016
NIH (2016c) Lometrexol. http://www.cancer.gov/publications/dictionaries/cancer-drug?cdrid=41670. Accessed 16 May 2016
NIH (2016d) Pyrimethamine. https://pubchem.ncbi.nlm.nih.gov/compound/pyrimethamine. Accessed 6 May 2016
NIH (2016e) Sulfasalazine. https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682204.html. Accessed 5 May 2016
NIH (2016f) Triamterene and hydrochlorothiazide https://www.nlm.nih.gov/medlineplus/druginfo/meds/a601125.html. Accessed 5 May 2016
NIH (2016g) Cholestyramine. https://www.nlm.nih.gov/medlineplus/druginfo/meds/a682672.html. Accessed 12 May 2016
NIH (2016h) Metformin. https://www.nlm.nih.gov/medlineplus/druginfo/meds/a696005.html. Accessed 12 July 2016
Norris RE, Adamson PC (2010) Clinical potency of methotrexate, aminopterin, talotrexin and pemetrexed in childhood leukemias. Cancer Chemother Pharmacol 65(6):1125–1130. https://doi.org/10.1007/s00280-009-1120-8
Nzila A, Okombo J, Molloy AM (2014) Impact of folate supplementation on the efficacy of sulfadoxine/pyrimethamine in preventing malaria in pregnancy: the potential of 5-methy-tetrahydrofolate. J Antimicrob Chemother 69(2):323–330. https://doi.org/10.1093/jac/dkt394
Ono H, Sakamoto A, Eguchi T, Fujita N, Nomura S, Ueda H, Sakura N, Ueda K (1997) Plasma total homocysteine concentrations in epileptic patients taking anticonvulsants. Metabolism 46(8):959–962. https://doi.org/10.1016/S0026-0495(97)90087-1
Ouma P, Parise ME, Hamel MJ, Ter Kuile FO, Otieno K, Ayisi JG, Kager PA, Steketee RW, Slutsker L, van Eijk AM (2006) A randomized controlled trial of folate supplementation when treating malaria in pregnancy with sulfadoxine-pyrimethamine. PLoS Clin Trials 1(6):e28. https://doi.org/10.1371/journal.pctr.0010028
Ozlu SG, Erguven M, Hamzah OY (2012) Do vitamin B12 levels need to be evaluated in FMF cases having long term colchicine treatment? Ann Paediatr Rheum 1(2):65–70. https://doi.org/10.5455/apr.041020120631
Palomba S, Falbo A, Giallauria F, Russo T, Tolino A, Zullo F, Colao A, Orio F (2010) Effects of metformin with or without supplementation with folate on homocysteine levels and vascular endothelium of women with polycystic ovary syndrome. Diabetes Care 33(2):246–251. https://doi.org/10.2337/dc09-1516
Palopoli JJ, Waxman J (1987) Colchicine neuropathy or vitamin B12 deficiency neuropath? N Eng. J Med 317:1290–1291. https://doi.org/10.1056/NEJM198711123172012
Peters GJ, Hooijberg JH, Kaspers GJL, Jansen G (2005) Folates and antifolates in the treatment of cancer; role of folic acid supplementation on efficacy of folate and non-folate drugs. Trends Food Sci Technol 16:289–297. https://doi.org/10.1016/j.tifs.2005.03.008
Petersen KM, Eplov K, Nielsen TK, Jimenez-Solem E, Petersen M, Broedbaek K, Popik SD, Hansen LK, Poulsen HE, Andersen JT (2016) The effect of trimethoprim on serum folate levels in humans: a randomized, double-blind, placebo-controlled trial. Am J Ther 23(2):e382–e387. https://doi.org/10.1097/MJT.0000000000000372
Pietrzik K, Bailey L, Shane B (2010) Folic acid and l-5-methyltetrahydrofolate: comparison of clinical pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 49(8):535–548. https://doi.org/10.2165/11532990-000000000-00000
Pizzorno G, Sokoloski JA, Cashmore AR, Moroson BA, Cross AD, Beardsley GP (1991) Intracellular metabolism of 5,10-dideazatetrahydrofolic acid in human leukemia cell lines. Mol Pharmacol 39(1):85–89
Porter K, Hoey L, Hughes CF, Ward M, McNulty H (2016) Causes, consequences and public health implications of low B-vitamin status in ageing. Nutrients 8(11):pii:E725. https://doi.org/10.3390/nu8110725
Preece J, Reynolds EH, Johnson AL (1971) Relation of serum to red cell folate concentrations in drug-treated epileptic patients. Epilepsia 12(4):335–340. https://doi.org/10.1111/j.1528-1157.1971.tb04381.x
Quinlivan EP, McPartlin J, Weir DG, Scott J (2000) Mechanism of the antimicrobial drug trimethoprim revisited. FASEB J 14(15):2519–2524. https://doi.org/10.1096/fj.99-1037com
Raghavan R, Fallin MD, Wang X (2016) Maternal plasma folate, vitamin B12 levels and multivitamin supplementation during pregnancy and risk of autism spectrum disorder in the Boston birth cohort. FASEB J 30:151–156
Raghavan R, Riley AW, Volk H, Caruso D, Hironaka L, Sices L, Hong X, Wang G, Ji Y, Brucato M, Wahl A, Stivers T, Pearson C, Zuckerman B, Stuart EA, Landa R, Fallin MD, Wang X (2018) Maternal multivitamin intake, plasma folate and vitamin B12 levels and autism spectrum disorder risk in offspring. Paediatr Perinat Epidemiol 32(1):100–111. https://doi.org/10.1111/ppe.12414
Ray MS, Muggia FM, Leichman CG, Grunberg SM, Nelson RL, Dyke RW, Moran RG (1993) Phase I study of (6R)-5,10-dideazatetrahydrofolate: a folate antimetabolite inhibitory to de novo purine synthesis. J Natl Cancer Inst 85(14):1154–1159. https://doi.org/10.1093/jnci/85.14.1154
Rezaei S, Shab-Bidar S, Abdulahi Abdurahman A, Djafarian K (2017) Oxcarbazepine administration and the serum levels of homocysteine, vitamin B12 and folate in epileptic patients: a systematic review and meta-analysis. Seizure 45:87–94. https://doi.org/10.1016/j.seizure.2016.11.016
Richens A, Waters AH (1971) Acute effect of phenytoin on serum folate concentration. Br J Pharmacol 41(2):415
Roberts JD, Poplin EA, Tombes MB, Kyle B, Spicer DV, Grant S, Synold T, Moran R (2000) Weekly lometrexol with daily oral folic acid is appropriate for phase II evaluation. Cancer Chemother Pharmacol 45(2):103–110. https://doi.org/10.1007/s002800050017
Rosowsky A (1999) PT523 and other aminopterin analogs with a hemiphthaloyl-l-ornithine side chain: exceptionally tight-binding inhibitors of dihydrofolate reductase which are transported by the reduced folate carrier but cannot form polyglutamates. Curr Med Chem 6(4):329–352
Ruscin JM, Page RL, Valuck RJ (2002) Vitamin B(12) deficiency associated with histamine(2)-receptor antagonists and a proton-pump inhibitor. Ann Pharmacother 36(5):812–816. https://doi.org/10.1345/aph.10325
Ryznychuk MO, Kryvchanska MI, Lastivka IV, Bulyk RY (2018) Incidence and risk factors of spina bifida in children. Wiad Lek 71:339–344
Sakhri L, Pinsolle J, Moro-Sibilot D, Pluchart H (2017) Unusually prolonged pemeterxed cytotoxicity in a patient with a lung adenocarcinome: a case report. J Med Case Rep 11(1):262. https://doi.org/10.1186/s13256-017-1436-7
Sander JW, Patsalos PN (1992) An assessment of serum and red blood cell folate concentrations in patients with epilepsy on lamotrigine therapy. Epilepsy Res 13(1):89–92. https://doi.org/10.1016/0920-1211(92)90011-H
Sanjoaquin MA, Allen N, Couto E, Roddam AW. Key TJ (2005) Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer 113:825–828. https://doi.org/10.1002/ijc.20648
Sauer J, Mason BJ, Choi SW (2009) Too much folate—a risk factor for cancer and cardiovascular disease? Curr Opin Clin Nutr Metab Care 12(1):30–36. https://doi.org/10.1097/MCO.0b013e32831cec62
Schmidt RJ, Tancredi DJ, Ozonoff S, Hansen RL, Hartiala J, Allayee H, Schmidt LC, Tassone F, Hertz-Picciotto I (2012) Maternal periconceptional folic acid intake and risk of autism spectrum disorders and development delay in the CHARGE (Children Autism Risks from Genetics and Environment) case-control study. Am J Clin Nutr 96(1):80–89. https://doi.org/10.3945/ajcn.110.004416
Scholl TO, Johnson WG (2000) Folic acid: influence on the outcome of pregnancy. Am J Clin Nutr 71:1295–1303. https://doi.org/10.1093/ajcn/71.5.1295s
Schornagel JH, Verweij J, de Mulder PHM, Cognetti F, Vermorken JB, Cappelaere P, Armand JP, Wildiers J, de Graeff A, Clavel M, Sahmoud T, Kirkpatrick A, Lefebvre JL (1995) Randomized phase III trial of edatrexate versus methotrexate in patients with metastatic and/or recurrent squamous cell carcinoma of the head and neck: a European Organization for Research and Treatment of Cancer Head and Neck Cancer Cooperative Group Study. J Clin Oncol 13:1649–1655. https://doi.org/10.1200/JCO.1995.13.7.1649
Schultz RM, Patel VF, Worzalla JF, Shih C (1999) Role of thymidylate synthase in the antitumor activity of the multitargeted antifolate, LY231514. Anticancer Res 19(1A):437–443
Schwaninger M, Ringleb P, Winter R, Kohl B, Fiehn W, Rieser PA, Walter-Sack I (1999) Elevated plasma concentrations of homocysteine and antiepileptic drug treatment. Epilepsia 40(3):345–350. https://doi.org/10.1111/j.1528-1157.1999.tb00716.x
Scott JM (1999) Folate and vitamin B12. Proc Nutr Soc 58(2):441–448
Seeger DR, Cosulich DB, Smith JR Jr, Hultquist ME (1949) Analogs of pteroylglutamic acid. III. 4-amino derivaties. J Am Chem Soc 71:1753. https://doi.org/10.1021/ja01173a061
Seidahmed MZ, Abdelbasit OB, Shaheed MM, Alhussein KA, Miqdad AM, Khalil MI, Al-Enazy NM, Salih MA (2014) Epidemiology of neural tube defects. Saudi Med J 35(1):S29–S35
Selhub J, Dhar GJ, Rosenberg IH (1978) Inhibition of folate enzymes by sulfasalazine. J Clin Investig 61(1):221–224. https://doi.org/10.1172/JCI108921
Sen Gupta D, Thavarajah D, Knutson P, Thavarajah P, McGee RJ, Coyne CJ, Kumar S (2013) Lentils (Lens culinaris L.), a rich source of folates. J Agric Food Chem 61(32):7794–7799. https://doi.org/10.1021/jf401891p
Sener U, Zorlu Y, Karaguzel O, Ozdamar O, Coker I, Topbas M (2006) Effects of common anti-epileptic drug monotherapy on serum levels of homocysteine, vitamin B12, folic acid and vitamin B6. Seizure 15(2):79–85. https://doi.org/10.1016/j.seizure.2005.11.002
Seremak-Mrozikiewicz A (2013) Metafolin—alternativefor folate deficiency supplementation in pregnant women. Ginekol Pol 84(7):641–646
Seshardi S, Beiser A, Selhub J, Jacques PF, Rosenberg IH, D´Agostino RB, Wilson PW, Wolf PA (2002) Plasma homocysteine as a risk factor for dementia and Alzheimer’s disease. N Engl J Med 346:476–483. https://doi.org/10.1056/NEJMoa011613
Shane B (2011) Folate status assessment history: implications for measurement of biomarkers in NHANES. Am J Clin Nutr 94(1):337S–342S. https://doi.org/10.3945/ajcn.111.013367
Sharma TK, Vardey SK, Sitaraman S (2015) Evaluate the effect of valproate monotherapy on the serum homocysteine, folate and vitamin B12 levels in epileptic children. Clin Lab 61(8):933–940. https://doi.org/10.7754/Clin.Lab.2015.141230
Sharma TK, Vardey SK, Sitaraman S (2016) Serum homocysteine, folate, and vitamin B12 levels in carbamazepine treated epileptic children. Clin Lab 62(7):1217–1224. https://doi.org/10.7754/Clin.Lab.2015.150911
Sharp L, Little J (2004) Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review. Am J Epidemiol 159:423–443
Shere M, Bapat P, Nickel C, Kapur B, Koren G (2015a) The effectiveness of folate-fortified oral contraceptives in maintaining optimal folate levels to protect against neural tube defects: a systematic review. J Obstet Gynaecol Can 37(6):527–533. https://doi.org/10.1016/S1701-2163(15)30229-2
Shere M, Bapat P, Nickel C, Kapur B, Koren G (2015b) Association between use of oral contraceptives and folate status: a systematic review and meta-analysis. J Obstet Gynaecol Can 37(5):430–438. https://doi.org/10.1016/S1701-2163(15)30258-9
Shojania AM, Wylie B (1979) The effect of oral contraceptives on vitamin B12 metabolism. Am J Obstet Gynecol 135(1):129–134
Smith AD (2007) Folic acid fortification: the good, the bad, and the puzzle of vitamin B-12. Am J Clin Nutr 85(1):3–5. https://doi.org/10.1093/ajcn/85.1.3
Smulders YM, de Man AM, Stehouwer CD, Slaats EH (1998) Trimethoprim and fasting plasma homocysteine. Lancet 352(9143):1827–1828. https://doi.org/10.1016/S0140-6736(05)79890-1
Stanhewicz AE, Kenney WL (2017) Role of folic acid in nitric oxide bioavailability and vascular endothelial function. Nutr Rev 75(1):61–70. https://doi.org/10.1093/nutrit/nuw053
Stargrove MB, Treasure J, McKee D (2008) Herb, nutrient, and drug interactions: clinical implications and therapeutic strategies. Mosby Elsevier, St. Louis, pp 198–217
Steegers-Theunissen RP, Van Rossum JM, Steegers EA, Thomas CM, Eskes TK (1993) Sub-50 oral contraceptives affect folate kinetics. Gynecol Obstet Investig 36(4):230–233. https://doi.org/10.1159/000292635
Stopa EG, O’Brien Katz M (1979) Effect of colchicine on guinea pig intrinsic factor-vitamin B12 receptor. Gastroenterology 76:309–314
Stüchler D, Holzer B (1980) Low serum folate among persons taking Fansidar (pyrimethamine plus sulfadoxine) for prophylaxis of malaria. Acta Trop 37:243–248
Sütterlin MW, Bussen SS, Rieger L, Dietl J, Steck T (2003) Serum folate and vitamin B12 levels in women using modern oral contraceptives containing 20 mg ethinyl estradiol. Eur J Obstet Gynecol Reprod Biol 107:57–61. https://doi.org/10.1016/S0301-2115(02)00371-8
Takimoto CH (1996) New antifolates: pharmacology and clinical applications. Oncologist 1:68–81
Tamura T, Aiso K, Johnston KE, Black L, Faught E (2000) Homocysteine, folate, vitamin B-12 and vitamin B-6 in patients receiving antiepileptic drug monotherapy. Epilepsy Res 40(1):7–15. https://doi.org/10.1016/S0920-1211(00)00101-7
Taylor IW, Slowiaczek P, Friedlander ML, Tattersall MH (1985) Selective toxicity of a new lipophilic antifolate, BW301U, for methotrexate-resistant cells with reduced drug uptake. Cancer Res 45(3):978–982
Taylor TN, Farkouh RA, Graham JB, Colligs A, Lindermann M, Lynen R, Candrilli SD (2011) Potential reduction in neural tube defects associated with use of metafolin-fortified oral contraceptives in the United States. Am J Obstet Gynecol 205(5):460.e1–460.e8. https://doi.org/10.1016/j.ajog.2011.06.048
Theti DS, Jackman AL (2004) The role of alpha-folate receptor-mediated transport in the antitumor activity of antifolate drugs. Clin Cancer Res 10(3):1080–1089. https://doi.org/10.1158/1078-0432.CCR-03-0157
Triedman JK, Newburger JW (2016) Trends in congenital heart disease: the next decade. Circulation 133(25):2716–2733. https://doi.org/10.1161/CIRCULATIONAHA.116.023544
Tsunematsu K, Kudo G, Shimoda M, Kokue E, Hayama T (1990) Effects of pyrimethamine and folic acid on plasma level of 5-methyltetrahydrofolic acid in rats. Congenit Anom 30(2):113–120. https://doi.org/10.1111/j.1741-4520.1990.tb00501.x
Ulrich CM, Yasui Y, Storb R, Schubert MM, Wagner JL, Bigler J, Ariail KS, Keener CL, Li S, Liu H, Farin FM, Potter JD (2001) Pharmacogenetics of methotrexate: toxicity among marrow transplantation patients varies with the methylenetetrahydrofolate reductase C677T polymorphism. Blood 98(1):231–234
Urquhart BL, Gregor JC, Chande N, Knauer MJ, Tirona RG, Kim RB (2010) The human proton-coupled folate transporter (hPCFT): modulation of intestinal expression and function by drugs. Am J Physiol Gastrointest Liver Physiol 298(2):G248–G254. https://doi.org/10.1152/ajpgi.00224.2009
Van Cutsem E, Cunningham D, Maroun J, Cervantes A, Glimelius B (2002) Raltitrexed: current clinical status and future directions. Ann Oncol 13:513–522. https://doi.org/10.1093/annonc/mdf054
Van Gelder MM, van Rooij IA, Miller RK, Zielhuis GA, de Jong-van den Berg LT, Roeleveld N (2010) Teratogenic mechanisms of medical drugs. Hum Reprod Update 16(4):378–394. https://doi.org/10.1093/humupd/dmp052
van der Wilt CL, Smid K, Peters GJ (2002) Effects of antifolates on the binding of 5-fluoro-2′-deoxyuridine monophosphate to thymidylate synthase. Biochem Pharmacol 64(4):669–675. https://doi.org/10.1016/S0006-2952(02)01219-4
Verrotti A, Pascarella R, Trotta D, Giuva T, Morgese G, Chiarelli F (2000) Hyperhomocysteinemia in children treated with sodium valproate and carbamazepine. Epilepsy Res 41(3):253–257. https://doi.org/10.1016/S0920-1211(00)00150-9
Vidmar M, Grželj J, Geršak K, Mlinarič-Raščan I (2016) Spremenjena aktivnost encima 5,10-metilentetrahidrofolat reduktaza (MTHFR) kot dejavnik tveganja za številne bolezni. Zdravniški Vestnik 85(5/6):324–336
Vilaseca MA, Monros E, Arthuch R, Colomé C, Farré C, Valls C, Cardo E, Pineda M (2000) Anti-epileptic drug treatment in children: hyperhomocysteinemia. B-vitamins and the 677C → T mutation of the methylenetetrahydrofolate reductase gene. Eur J Paediatr Neurol 4:269–277. https://doi.org/10.1053/ejpn.2000.0379
Vurucu S, Gulgun M, Yesilkaya E, Unay B, Akin R (2009) The effects of oxcarbazepine treatment on vitamin B12 and folate levels, thyroid functions, sex hormones, and bone mineral density in epileptic patients. Cent Eur J Med 4(3):310–314. https://doi.org/10.2478/s11536-009-0040-7
Wang H-X, Wahlin A, Basun H, Fastborn J, Winblad B, Frattelioni L (2001) Vitamin B12 and folate in relation to the development of Alzheimer’s disease. Neurology 56:1188–1194
Wang ES, O´Connor O, She Y, Zelenetz AD, Sirotnak FM, Moore MA (2003) Activity of a novel anti-folate (PDX, 10-propargyl 10-deazaaminopterin) against human lymphoma is superior to methotrexate and correlates with tumor RFC-1 gene expression. Leuk Lymphoma 44(6):1027–1035. https://doi.org/10.1080/1042819031000077124
Wang M, Li K, Zhao D, Li L (2017) The association between maternal use of folic acid supplements during pregnancy and risk of autism spectrum disorders in children: a meta analysis. Mol Autism 8:51. https://doi.org/10.1186/s13229-017-0170-8
Webb DI, Chodos RB, Mahar CQ, Faloon WW (1968) Mechanism of vitamin B12 malabsorption in patients receivinig colchicine. N Engl J Med 279(16):845–850. https://doi.org/10.1056/NEJM196810172791602
Wegner C, Nau H (1992) Alteration of embryonic folate metabolism by valproic acid during organogenesis: implications for mechanism of teratogenesis. Neurology 42(5):17–24
Weston J, Bromley R, Jackson CF, Adab N, Clayton-Smith J, Greenhalgh J, Hounsome J, McKay AJ, Smith T, Marson AG (2016) Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev CD010224. https://doi.org/10.1002/14651858.CD010224.pub2
Wilson SM, Bivins BN, Russell KA, Bailey LB (2011) Oral contraceptive use: impact on folate, vitamin B6, and vitamin B12 status. Nutr Rev 69(10):572–583. https://doi.org/10.1111/j.1753-4887.2011.00419.x
World Health Organization (WHO) (2018) Epilepsy. http://www.who.int/news-room/fact-sheets/detail/epilepsy. Accessed 18 June 2018
Worthington P, Schechter L (2010) Drug–nutrient interactions involving folate. In: Boullata JI, Armenti VT (eds) Handbook of drug–nutrient interactions, 2nd edn. Humana Press, New York, pp 513–537
Yilmaz R, Ozer S, Ozyurt H, Erkorkmaz U (2011) Serum vitamin B12 status in children with familial mediterranean fever receiving colchicine treatment. HK J Paediatr 16:3–8
Zimmerman J, Selhub J, Rosenberg IH (1986) Competitive inhibition of folic acid absorption in rat jejunum by triamterene. J Lab Clin Med 108(4):272–276
Acknowledgements
This work was supported by the Slovenian Research Agency Grant (no. P3-0124). We thank Tomaž Janez Bevec for proofreading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interest.
Rights and permissions
About this article
Cite this article
Vidmar, M., Grželj, J., Mlinarič-Raščan, I. et al. Medicines associated with folate–homocysteine–methionine pathway disruption. Arch Toxicol 93, 227–251 (2019). https://doi.org/10.1007/s00204-018-2364-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00204-018-2364-z